LATEST

• BUSINESS Regenxbio Clears Path to Resubmit Hunter Syndrome Gene Therapy
  June 24, 2026

• BUSINESS Merck Biopharma Files Lurbinectedin for SCLC in Japan
  June 24, 2026

• REGULATORY Japan Awards Sakigake Tag to AbbVie’s Bispecific Etentamig
  June 24, 2026

• BUSINESS FRONTEO Joins Dementia Prevention Cohort Study with KIBIT AI
  June 24, 2026

• BUSINESS Alfresa Invests in Digital Health Startup eMind
  June 24, 2026

• BUSINESS Daito Scores China Approval for Myonal Generic
  June 24, 2026

• BUSINESS Sumitomo Pharma’s Average Pay Jumps on Workforce Rejig
  June 24, 2026

• BUSINESS Nippon Shinyaku, Boston Children’s Hospital to Partner in Neurology Research
  June 24, 2026

• REGULATORY Japan Grants Orphan Status to Vanda, Quoin Drugs, and Lots More
  June 24, 2026

• BUSINESS Fycompa Generics Head for Summer Launch as Key Patent Expires
  June 23, 2026

• REGULATORY Carvykti Earlier Use Up for Japan Panel Review on June 29
  June 23, 2026

• REGULATORY Kampo Industry Calls for Predictable Drug Pricing to Support Stable Supply
  June 23, 2026

• BUSINESS ASKA’s Relugolix Combo Hits Primary Goal in Japan PIII Fibroid Study
  June 23, 2026

• BUSINESS Rege Nephro Raises 1.22 Billion Yen to Advance ADPKD Drug, iPSC Kidney Program
  June 23, 2026

• BUSINESS Japan OTC Drug Market Falls for Third Straight Month in May: Intage
  June 23, 2026

• REGULATORY Yoshida Pharma Plant Hit with Improvement Order over Testing Violations
  June 23, 2026

• BUSINESS Lilly Japan Names Karla Alcazar as New President
  June 22, 2026

• ORGANIZATION Boehringer’s Hasson Appointed EFPIA Japan Vice Chair
  June 22, 2026

• REGULATORY Japan Approves Wegovy MASH Use, AstraZeneca’s Etcamah, Others
  June 22, 2026

• REGULATORY Japan on Alert over US MFN Drug Pricing Policy: Health Minister
  June 22, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• …
• Next ›
• 最終 »